Maintaining muscle mass also matters on GLP-1 diets, as weight loss can sometimes lead to muscle loss
BPC-157 Peptide Regulatory Status in Canada Health Canada Regulatory Status BPC-157 is not an authorized health product in Canada and does not carry a Drug Identification Number (DIN), Natural Product Number (NPN), or Homeopathic Drug Number (DIN-HM) issued by Health Canada
Since GLP-1s are relatively new drugs, their long-term side effects are unknown
MODALITA' D'USO: Assumere 3 capsule al giorno, preferibilmente al mattino o subito prima dell'allenamento, con abbondante liquido
This condition has been found to directly or indirectly induce drug resistance in breast cancer through various mechanisms 5
Antibodies The following rabbit polyclonal antibodies were used: anti-GSTM2 (#ab125,102, Abcam, Cambridge, UK, 1:1000), anti-GSTM2 (#A13,496, ABclonal, Wuhan, China, 1:2000), anti-GAPDH (#CSB-PA00025A0Rb Flarebio Biotech LLC, College Park, MD, USA, 1:1000), anti-CIDEC (#D222114, Sangon Biotech, Shanghai, China, 1:1000), anti-CIDEC (#12287-1-AP, Proteintech, Rocky Hill, NJ, USA, 1:1000), anti-ADRP/perilipin2 (#15294-1-AP, Proteintech), anti-DGAT2 (#bs-12,998R, BIOSS, Beijing, China), anti-DGAT2 (#A13,891, ABclonal, Wuhan, China, 1:2000), anti-GPAT4 (#bs-15,587R, BIOSS), anti-SREBP1 (#14,088-1-AP, Proteintech), and anti-PCYT1A (#bs-11306R, BIOSS), anti-PCYT1A (#A5935, ABclonal, Wuhan, China, 1:1000)